Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-03

Clinical Trial Update: Microdystrophin Gene Transfer Study in Adolescents and Children With DMD [Phase 1, Phase 2]

View source ↗

Summary

Solid Biosciences is running a Phase 1/2 microdystrophin gene transfer study in children and adolescents with Duchenne muscular dystrophy; the trial is active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microdystrophin gene transfer therapy

Snippet

Sponsor: Solid Biosciences Inc. | Conditions: Duchenne Muscular Dystrophy | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING